Home Heterozygous GHR gene mutation in a child with idiopathic short stature
Article
Licensed
Unlicensed Requires Authentication

Heterozygous GHR gene mutation in a child with idiopathic short stature

  • Sara Pagani , Vibor Petkovic , Beatrice Messini , Cristina Meazza , Elena Bozzola , Primus-E. Mullis and Mauro Bozzola EMAIL logo
Published/Copyright: October 23, 2013

Abstract

Several monogenic defects have been reported to be associated with idiopathic short stature. Focusing on growth hormone receptor (GHR)-gene alterations, the heterozygosity of the same gene defect may be associated with a range of growth deficits. We found a heterozygous mutation (V144I) within exon 6 of the GHR gene in a patient with a low level of insulin-like growth factor I (IGF-I), normal level of GH, and severe short stature. Despite the lack of statistical difference, an overall tendency for reduced wt-GH-induction of GHR activation and Jak/Stat signalling in cells transiently expressing GHR-V144I alone or co-expressing wt-GHR compared to cells expressing only wt-GHR was found when GH doses were increased. Our results suggest that, although GHR sequence variants are responsible for some functional alterations commonly observed in children with idiopathic short stature, these changes may not explain all the height deficits observed in these subjects.


Corresponding author: Mauro Bozzola, MD, Internal Medicine and Therapeutics Department, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Piazzale Golgi, 2, 27100 Pavia, Italy, Phone: +390382501270, Fax: +390382502876, E-mail:
aThese authors contributed equally to the writing of the manuscript.

Acknowledgments

The authors are grateful to Laurene Kelly for her English language revision of the paper.

References

1. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, et al. ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210–7.Search in Google Scholar

2. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, et al. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008;18:89–110.Search in Google Scholar

3. Lettre G, Butler JL, Ardilie KG, Hirschhorn JN. Common genetic variation in eight genes of the GH/IGF-I axis does not contribute to adult height variation. Hum Genet 2007;122:129–39.Search in Google Scholar

4. Wit JM, van Duyvenvoorde HA, Scheltinga SA, De Bruin S, Hafkenscheid L, et al. Genetic analysis of short children with apparent growth hormone insensitivity. Horm Res Paediatr 2012;77:320–33.Search in Google Scholar

5. Kemper KE, Vissher PM, Goddard ME. Genetic architecture of body size in mammals. Genome Biology 2012;13:244–57.Search in Google Scholar

6. Gairdner D, Pearson J. A growth chart for premature and other infants. Arch Dis Child 1971;46:783–7.Search in Google Scholar

7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966;41:454–71.Search in Google Scholar

8. Richmond EJ, Rogol AD. Growth hormone deficiency in children. Pituitary 2008;11:115–20.Search in Google Scholar

9. Tetlow LJ, Clayton PE. Tests and normal values in pediatric endocrinology. In: Brook C, Clayton P, Brown R, editors. Clinical pediatric endocrinology. Oxford: Blackwell Publishing, 2006:523–64.Search in Google Scholar

10. Ross RJ, Esposito N, Shen XY, von Laue S, Chew SL, et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Molecular Endocrinology 1997;11:265–73.Search in Google Scholar

11. Von Laue S, Finidori J, Maamra M, Shen XY, Justice S, et al. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone. J Endocrinol 2000;165:301–11.Search in Google Scholar

12. Moutoussamy S, Kelly PA, Finidori J. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem 1998;255:1–11.Search in Google Scholar

13. Sotiropoulos A, Moutoussamy S, Renaudie F, Clauss M, Kayser C, et al. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol Endocrinol 1996;10:998–1009.Search in Google Scholar

14. Mullis PE. Biological determinants of responsiveness to growth hormone: pharmacogenomics and personalized medicine. Endocr Dev 2010;18:67–82.Search in Google Scholar

15. Rakover Y, Silbergeld A, Lavi I, Masalha R, Shlomo IB. Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome? Eur J Endocrinol 2002;146:319–23.Search in Google Scholar

16. Rosenfeld RG. Molecular mechanisms of IGF-I deficiency. Horm Res 2006;65(Suppl 1):15–20.Search in Google Scholar

17. Goddard AD, Dowd P, Chernausek S, Geffner M, Gertner J, et al. Partial growth-hormone insensitivity:the role of growth-hormone receptor mutations in idiopathic short stature. J Pediatr 1997;131(1 Pt 2):S51–5.Search in Google Scholar

18. Hujeirat Y, Hess O, Shalev S, Tenenbaum-Rakover Y. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature. Horm Res 2006;65:210–6.Search in Google Scholar

19. Sanchez JE, Perera E, Baumbach L, Cleveland WW. Growth hormone receptor mutations in children with idiopathic short stature. J Clin Endocrinol Metab 1998;83:4079–83.Search in Google Scholar

20. Amselem S, Duquesnoy P, Duriez B, Duriez B, Dastot F, et al. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet 1993;2:355–9.Search in Google Scholar

21. Bonioli E, Tarò M, La Rosa C, Citana A, Bertorelli R, et al. Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature. Growth horm IGF Res 2005;15:405–10.Search in Google Scholar

22. Lango HA, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832–8.Search in Google Scholar

Received: 2013-9-4
Accepted: 2013-9-11
Published Online: 2013-10-23
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Downloaded on 20.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0359/html
Scroll to top button